N 3554S
Alternative Names: (S)-alpha-dihydrodecaprenyl phosphate; Dihydrodecaprenyl phosphate; N 1554Latest Information Update: 12 Dec 2007
At a glance
- Originator Nisshin Pharma
- Class Antineoplastics; Polyisoprenyl phosphates
- Mechanism of Action Glycosylation stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 12 Dec 2007 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 10 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 20 Jul 2001 This compound is still in active development